Jianli Dong, MD, PhD, MMS

Director, Molecular Pathology (PhD)

Calculated based on number of publications stored in Pure and citations from Scopus
1991 …2024

Research activity per year

Personal profile

Research Strategic Pillar

Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):

Research interests

Because of my certification in Clinical Molecular Genetics and Genomics (MGG) and Laboratory Genetics and Genomics (LGG) by the American Board of Medical Genetics and Genomics (ABMGG), I am most interested in research, development, and validation studies of molecular, genetics and genomics biomarkers to improve diagnosis and management of human diseases. I’m also interested in BRAF-MEK-ERK and p16-CDK4/6-RB pathways in cancer biology and as therapeutic targets in melanoma and other cancers.

Education/Academic qualification

Clinical Molecular Genetics, Clinical Fellowship, Mount Sinai School of Medicine, New York

… → 2001

Human Genetics, Research Fellowship, Yale University School of Medicine

… → 1999

Genetics, PhD, University of Toronto, Canada

… → 1998

Molecular Biology, MSc, University of Toronto, Canada

… → 1992

Medicine, MD, Southern Medical University, Guangzhou, China

… → 1985

Research Strategic Pillar Keywords

  • Life Span Health


Dive into the research topics where Jianli Dong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or